Avacta publishes interim six-month results

Avacta, a provider of technologies and services to the pharmaceutical and diagnostics markets, has announced its interim results for the six months ended 31 January 2010.

The company highlighted strong growth in group revenues, which increased more than fourfold to £0.89m  

Operating loss before non-recurring items and share-based payment was £1.05m, compared with £1.04m in 2009, while loss per share had reduced to £0.1, compared with £0.12 for the previous year.